Medications for Common Variable Immunodeficiency

16 results

Asceniv (human immunoglobulin g)

(HUMAN IMMUNOGLOBULIN G)
ADMA Biologics, Inc.
Usage: ASCENIV is indicated for the treatment of primary humoral immunodeficiency (PI) in adults and adolescents aged 12 to 17. This includes conditions such as congenital agammaglobulinemia, common variable immunodeficiency (CVID), X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies (SCID).

Bivigam (immune globulin intravenous (human) 10%)

(Immune Globulin Intravenous (Human) 10%)
ADMA Biologics, Inc.
Usage: BIVIGAM is indicated for treating primary humoral immunodeficiency in adults and children aged 2 years and older, including conditions such as common variable immunodeficiency, X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.

Cutaquig (immunoglobulin g)

(immunoglobulin G)
Pfizer Laboratories Div Pfizer Inc
Usage: CUTAQUIG is indicated for replacement therapy in adults and pediatric patients aged 2 and older with primary humoral immunodeficiency (PI), including conditions like common variable immunodeficiency, X-linked agammaglobulinemia, and severe combined immunodeficiencies.

Cuvitru (immune globulin subcutaneous (human))

(Immune Globulin Subcutaneous (Human))
Takeda Pharmaceuticals America, Inc.
Usage: CUVITRU is indicated for replacement therapy in primary humoral immunodeficiency in patients aged two years and older, including conditions such as common variable immunodeficiency, X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.

Flebogamma (immune globulin (human))

(Immune Globulin (Human))
GRIFOLS USA, LLC
Usage: Flebogamma 5% DIF is indicated for the treatment of primary immunodeficiency in adults and pediatric patients aged 2 years and older, including conditions like common variable immunodeficiency, x-linked agammaglobulinemia, severe combined immunodeficiency, and Wiskott-Aldrich syndrome.

Gammagard liquid (immune globulin infusion (human))

(Immune Globulin Infusion (Human))
Takeda Pharmaceuticals America, Inc.
Usage: GAMMAGARD LIQUID is indicated for replacement therapy in primary immunodeficiency in patients aged two and older, as well as maintenance therapy to improve muscle strength in adults with multifocal motor neuropathy and to enhance neuromuscular function in adults with chronic inflammatory demyelinating polyneuropathy.

Gammaked (immune globulin (human))

(Immune Globulin (Human))
KEDRION BIOPHARMA, INC.
Usage: GAMMAKED is indicated for treating primary humoral immunodeficiency in patients 2 years and older, idiopathic thrombocytopenic purpura (ITP) in adults and children, and chronic inflammatory demyelinating polyneuropathy (CIDP) in adults to improve neuromuscular function and prevent relapse.

Gammaplex (human immunoglobulin g)

(HUMAN IMMUNOGLOBULIN G)
Bio Products Laboratory Limited
Usage: GAMMAPLEX 5% is indicated for replacement therapy in primary humoral immunodeficiency (PI) in patients aged 2 years and older, as well as for the treatment of chronic immune thrombocytopenic purpura (ITP) to increase platelet counts.

Gamunex-c (immune globulin (human))

(Immune Globulin (Human))
GRIFOLS USA, LLC
Usage: GAMUNEX-C is indicated for treating primary humoral immunodeficiency in patients aged 2 and older, idiopathic thrombocytopenic purpura (ITP) in adults and children, and chronic inflammatory demyelinating polyneuropathy (CIDP) in adults to enhance neuromuscular function and prevent relapses.
Octapharma USA Inc
Usage: Octagam is indicated for the treatment of primary humoral immunodeficiency diseases (PI), including congenital agammaglobulinemia, common variable immunodeficiency, X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies. It is administered as a 5% intravenous immune globulin solution.